Should I buy Strategy (MSTR) stock or is it too late?
⭐ The most reliable of them, either direction: TD Cowen — 67% of its targets hit on this sector (9 calls tested). It aims for $260 (+89 %), call made on July 1, 2026, maturing on July 1, 2027 (58 d ago).
Firm-by-firm track record on Strategy
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Canaccord Genuity | 67 % | +144.4 % | 18 | $175 +27% |
| BTIG | 43 % | +74.6 % | 7 | $250 +82% |
| TD Cowen | 75 % | +73.8 % | 8 | $260 +89% |
| Bernstein | 60 % | +52.0 % | 5 | $450 +228% |
| Benchmark | 55 % | +40.9 % | 11 | $435 +217% |
| Barclays | 57 % | +28.6 % | 7 | $125 -9% |
| Citigroup | 60 % | -5.6 % | 5 | $136 -1% |
| Cantor Fitzgerald | 20 % | -24.7 % | 5 | $186 +35% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $181, i.e. +31% from the current price ($137).
- The most reliable firm on MSTR, TD Cowen (75% hit rate, 8 scored calls), targets $260 (call made on June 30, 2026, maturing on June 30, 2027) (+89%) in its most recent call, and $620 (call made on September 16, 2025, maturing on September 16, 2026) (+351%) in the one coming due soonest.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on MSTR
Median target $181 (+31%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Strategy now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $181 (+31%), and TD Cowen (most reliable on MSTR, 75%) targets $260. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Strategy?
Not according to analysts: the median target ($181) is still +31% above the current price ($137) (most reliable on MSTR: TD Cowen, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Strategy still worth investing in?
It depends on the gap between the price ($137) and its estimated value: analysts target $181 on median (+31%), with 100% buys (most reliable on MSTR: TD Cowen, 75%). Cross-check with their real reliability on MSTR and the cautions above. Information, not advice.
What's the main risk in buying MSTR?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Strategy profile (consensus, analyst reliability, price target, performance).